Today: 1 May 2026
Browse Category

NYSE:UNH 10 December 2025 - 23 December 2025

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 22, 2025): Latest News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 22, 2025): Latest News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group shares closed Monday at $325.16, down 0.69%, underperforming the S&P 500’s 0.64% gain. After-hours trading saw little movement, with prices hovering just below the close. Investors remain cautious amid ongoing regulatory scrutiny and questions about the company’s operational turnaround. Trading volumes were thin ahead of the holiday.
23 December 2025
·
UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus

UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus

UnitedHealth Group shares traded near $325.48 on Dec. 22, down slightly from the previous close. The company released initial findings from independent reviews of its Medicare Advantage, care management, and Optum Rx operations, citing broadly sound practices but highlighting areas for improved oversight. UnitedHealth plans to complete most recommended changes by the end of 2025.
22 December 2025
·
UnitedHealth (UNH) Stock: Key Audit Updates, DOJ Risks, Earnings Outlook and Analyst Forecasts Before the Market Opens Dec. 22, 2025

UnitedHealth (UNH) Stock: Key Audit Updates, DOJ Risks, Earnings Outlook and Analyst Forecasts Before the Market Opens Dec. 22, 2025

UnitedHealth closed Friday at $327.42, down about one-third over the past year and near the lower end of its 52-week range. The company said it will make major operational changes after external audits of its health services and pharmacy benefit manager units, citing documentation issues in Medicare Advantage programs. Markets face thin holiday trading, with NYSE and Nasdaq closing early Dec. 24 and shut Dec. 25.
22 December 2025
··
UnitedHealth Group (UNH) Stock Week Ahead: Audit Overhaul, Trump’s Insurer Price Talks, and ACA Subsidy Deadline Drive the Outlook

UnitedHealth Group (UNH) Stock Week Ahead: Audit Overhaul, Trump’s Insurer Price Talks, and ACA Subsidy Deadline Drive the Outlook

UnitedHealth Group stock last traded near $327 ahead of the holiday-shortened week, with investors watching regulatory headlines and ongoing scrutiny of Medicare Advantage practices. Shares dropped nearly 10% intraday after former President Trump called for lower insurer prices before recovering. The company is implementing 23 operational changes following outside audits, with most set for completion by end-2025.
21 December 2025
·
UnitedHealth Group Stock (UNH) After Hours: Trump Premium Comments, New Audit “Action Plans,” and What to Watch Before the Next Market Open

UnitedHealth Group Stock (UNH) After Hours: Trump Premium Comments, New Audit “Action Plans,” and What to Watch Before the Next Market Open

UnitedHealth shares closed near $327 Friday after volatile trading triggered by President Trump’s call for insurers to cut prices and the company’s release of 23 operational action plans. The stock swung between $326.1 and $334.6 before settling just below its opening price, then edged slightly lower after hours.
20 December 2025
·
UnitedHealth Group Incorporated Stock (NYSE: UNH) News Today: Audit-Driven Overhaul, OptumRx Shift, and 2026 Forecasts (Dec. 19, 2025)

UnitedHealth Group Incorporated Stock (NYSE: UNH) News Today: Audit-Driven Overhaul, OptumRx Shift, and 2026 Forecasts (Dec. 19, 2025)

UnitedHealth Group shares rose 1.55% to $333.22 Friday after the company announced operational changes following external audits of its health services and pharmacy benefit units. CEO Stephen Hemsley said more than half of 23 action plans will be finalized by year-end, with all completed by Q1 2026. Audits cited documentation gaps in HouseCalls and called for more automation at OptumRx. UnitedHealth denies wrongdoing amid ongoing DOJ scrutiny.
19 December 2025
·
UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group shares traded around $326–$327 midday on Dec. 18, 2025, after a volatile year marked by a 32.6% price drop. A Reuters report highlighted possible sharp ACA premium hikes in 2026 and UnitedHealth’s warning that enrollment could fall by two-thirds if subsidies are not extended. Legislative uncertainty around ACA subsidies remains high.
18 December 2025
·
UnitedHealth Group (UNH) Stock After Hours Today: Key Headlines, Analyst Forecasts, and What to Watch Before the Market Opens Dec. 18, 2025

UnitedHealth Group (UNH) Stock After Hours Today: Key Headlines, Analyst Forecasts, and What to Watch Before the Market Opens Dec. 18, 2025

UnitedHealth Group shares closed at $331.51, down 0.81%, and slipped further to $330.19 in after-hours trading Wednesday. The drop followed a Guardian investigation into its nursing home program and a broader market decline, with the S&P 500 falling 1.16%. Trading volume was about half the three-month average. UnitedHealth denied wrongdoing in response to the report’s allegations.
18 December 2025
·
UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth (UNH) closed Monday down 0.22% at $341.10 and slipped to $340.14 after hours. The move followed Fitch’s downgrade of rival Humana, citing higher medical costs and weaker Medicare Advantage bonuses. UNH traded 6.3 million shares in a $337–$344.96 range. Industry commentary remains focused on rising expenses and regulatory pressure.
16 December 2025
···
UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth shares fell 1.27% to $337.51 as of 15:27 UTC Monday, trading in a narrow range amid legal headlines and sector rotation. The company will report full-year 2025 results and issue 2026 guidance before the market opens on January 27. A $2.21 quarterly dividend is set for payment December 16. Trading volume reached about 1.75 million shares.
15 December 2025
·
UnitedHealth Group (UNH) Stock News and Forecasts on Dec. 14, 2025: DOJ-Amedisys Deal, Optum Opioid Lawsuit, Earnings Date, and Analyst Targets

UnitedHealth Group (UNH) Stock News and Forecasts on Dec. 14, 2025: DOJ-Amedisys Deal, Optum Opioid Lawsuit, Earnings Date, and Analyst Targets

A federal court approved a DOJ settlement in UnitedHealth’s Amedisys merger case, requiring divestitures and a $1.1 million penalty. West Virginia filed suit against Optum over opioid sales allegations. UnitedHealth shares closed Friday at $341.84, up 1.5%. The company will report full-year 2025 earnings and 2026 guidance on Jan. 27.
14 December 2025
··
UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group shares closed Friday, Dec. 12, 2025, at $341.84, up 1.52%, capping a 5.6% weekly gain despite a broader market decline. The week included a federal court approving UnitedHealth’s $3.3 billion Amedisys acquisition with required divestitures, and a new opioid-related lawsuit filed by West Virginia against Optum.
13 December 2025
·
UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth shares closed Friday at $341.84, up 1.52%, defying a broader market decline. After-hours trading saw the stock dip to around $341.33. The company announced it will report full-year 2025 results and 2026 guidance on January 27, 2026. Managed-care stocks, including UNH, gained Friday amid renewed efforts in Congress to extend ACA subsidies.
12 December 2025
··
UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth shares closed at $336.73 on Dec. 11 and traded near $337.95 pre-market Friday, approaching a key technical level. A federal court approved the DOJ settlement for UnitedHealth’s $3.3 billion Amedisys acquisition, requiring divestiture of 164 home health and hospice sites. The stock’s 52-week range is $234.60 to $606.36. UnitedHealth and Optum also face a West Virginia lawsuit over alleged opioid oversupply.
12 December 2025
UnitedHealth Group (UNH) Stock After the Bell on Dec. 11, 2025 – And What to Watch Before the Dec. 12 Open

UnitedHealth Group (UNH) Stock After the Bell on Dec. 11, 2025 – And What to Watch Before the Dec. 12 Open

UnitedHealth Group shares closed Thursday at $336.50, up about 2.5% on volume near 7 million, as the Dow hit a record high. After-hours trading was quiet, with the stock near $336.70. UNH’s market cap stands at roughly $305 billion, still well below its 2025 peak near $600. Options activity surged, with contracts traded at about double the average share volume.
12 December 2025
··
US Stock Market Today: Dow Rockets to Record Above 48,700 as S&P 500 Hits New High, Nasdaq Slips on Oracle AI Jitters

US Stock Market Today: Dow Rockets to Record Above 48,700 as S&P 500 Hits New High, Nasdaq Slips on Oracle AI Jitters

The Dow Jones closed at a record 48,704, up 1.3%, while the S&P 500 also hit a new high at 6,900.99. The Nasdaq fell 0.25% to 23,594 as tech and AI stocks slid after Oracle shares dropped 11–13% on heavy AI spending and negative free cash flow. Three-quarters of S&P 500 stocks rose. The day followed a Fed rate cut and a spike in jobless claims.
11 December 2025
······
UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth shares climbed to $332–334 intraday on December 11, up from $319.97 on November 21, but remain down about 35% over the past year. The stock trades at a trailing P/E of 14.9×, below sector average, but a forward P/E of 19×, slightly above peers. Dividend yield stands at 2.8%, with the next payout set for December 16. DOJ probe and Medicare Advantage reset continue to weigh on outlook.
11 December 2025
·
UnitedHealth Group (UNH) Stock Forecast 2026: Can the Healthcare Giant Recover From 2025’s Crises?

UnitedHealth Group (UNH) Stock Forecast 2026: Can the Healthcare Giant Recover From 2025’s Crises?

UnitedHealth Group shares closed at about $324 on December 10, 2025, down roughly 39% over the past year. The company faced a series of shocks, including the December 2024 assassination of UnitedHealthcare’s CEO and a DOJ criminal probe into Medicare Advantage billing. Revenue rose 11–12% year over year to $334.4 billion for the first nine months of 2025.
10 December 2025
··
1 … 5 6 7 8 9

Stock Market Today

  • Organon Q1 CY2026 Revenue Falls Short of Estimates Amid Declining Sales
    April 30, 2026, 10:38 PM EDT. Organon (NYSE:OGN) posted Q1 CY2026 revenue of $1.46 billion, missing analyst estimates by 0.7% and declining 3.5% year-on-year. The pharmaceutical firm reported adjusted earnings per share (EPS) of $0.71, 16.8% below expectations, and adjusted EBITDA slightly missed forecasts at $415 million. Despite a rising operating margin of 18.2%, revenue growth has been subdued, with annual declines of 1.5% over two years and stagnant sales near five-year levels. Market capitalization stands at $3.5 billion. Analysts anticipate flat revenue over the next 12 months, reflecting ongoing challenges in demand despite product innovation. The results raise concerns on Organon's business quality and long-term growth prospects in the women's health segment post its 2021 spinoff from Merck.

Latest article

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
Go toTop